• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一个前瞻性吸毒人群队列中,冰毒使用与美沙酮维持治疗留存率之间的关系。

The relationship between crystal methamphetamine use and methadone retention in a prospective cohort of people who use drugs.

作者信息

Mackay Lindsay, Bach Paxton, Milloy M-J, Cui Zishan, Kerr Thomas, Hayashi Kanna

机构信息

British Columbia Centre on Substance Use, 400-1045 Howe Street, Vancouver, BC, V6Z 2A9, Canada; Department of Medicine, University of British Columbia, St. Paul's Hospital, 608-1081 Burrard Street, Vancouver, BC, V6Z 1Y6, Canada.

British Columbia Centre on Substance Use, 400-1045 Howe Street, Vancouver, BC, V6Z 2A9, Canada; School of Population and Public Health, University of British Columbia, 2206all, Vancouver, British Columbia, V6T 1Z3, Canada.

出版信息

Drug Alcohol Depend. 2021 Aug 1;225:108844. doi: 10.1016/j.drugalcdep.2021.108844. Epub 2021 Jun 24.

DOI:10.1016/j.drugalcdep.2021.108844
PMID:34182377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8812812/
Abstract

BACKGROUND

The efficacy of methadone in reducing morbidity and mortality associated with opioid use disorder is supported by a wealth of evidence, yet methadone retention is often poor. While crystal methamphetamine (methamphetamine) use has been recently increasing in many countries, the effect of frequency of methamphetamine use on methadone discontinuation has not been investigated. We aimed to examine whether frequency of methamphetamine use is associated with increased rates of methadone discontinuation among individuals on methadone.

DESIGN

Two harmonized ongoing open prospective cohort studies of community-recruited people who use illicit drugs with semi-annual follow-ups between 2014 and 2018.

SETTING

Vancouver, Canada.

PARTICIPANTS

A community recruited sample of people who use drugs.

INTERVENTION

A time-varying variable of self-reported methamphetamine use frequency within the past six months.

MEASUREMENTS

The primary outcome was time to discontinuation of methadone, defined as reporting not being on methadone at the time of a follow-up interview during the study period. We employed multivariable extended Cox regression analysis to examine the relationship between frequency of methamphetamine use and time to methadone discontinuation after adjusting for potential confounders.

FINDINGS

Of 875 eligible participants who contributed 2319 person-years of follow-up, 284 (32.5 %) discontinued methadone at least once during follow-up and 135 (15.4 %) reported more than weekly methamphetamine use at study baseline. In a multivariate analysis, in comparison to no use, ≥weekly use of methamphetamine remained independently associated with methadone discontinuation (adjusted hazard ratio [aHR] = 1.38, 95 % CI = 1.03-1.85).

CONCLUSIONS

A significant proportion of participants on methadone in this study reported more than weekly crystal methamphetamine use, which was associated with an increased risk of methadone discontinuation. Closer follow up, education, and treatment of methamphetamine use may be needed for this group to improve methadone retention.

摘要

背景

大量证据支持美沙酮在降低与阿片类物质使用障碍相关的发病率和死亡率方面的疗效,但美沙酮维持治疗的留存率往往较低。虽然近年来许多国家冰毒(甲基苯丙胺)的使用呈上升趋势,但甲基苯丙胺使用频率对美沙酮停药的影响尚未得到研究。我们旨在探讨甲基苯丙胺的使用频率是否与接受美沙酮治疗的个体中更高的美沙酮停药率相关。

设计

两项正在进行的开放式前瞻性队列研究,对社区招募的使用非法药物的人群进行了2014年至2018年的半年一次随访。

地点

加拿大温哥华。

参与者

社区招募的吸毒人群样本。

干预

过去六个月内自我报告的甲基苯丙胺使用频率这一随时间变化的变量。

测量

主要结局是美沙酮停药时间,定义为在研究期间的随访访谈时报告未服用美沙酮。我们采用多变量扩展Cox回归分析,在调整潜在混杂因素后,研究甲基苯丙胺使用频率与美沙酮停药时间之间的关系。

结果

在875名符合条件的参与者中,共随访了2319人年,其中284人(32.5%)在随访期间至少有一次停用美沙酮,135人(1

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc5/8812812/56c2b841493b/nihms-1773787-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc5/8812812/56c2b841493b/nihms-1773787-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adc5/8812812/56c2b841493b/nihms-1773787-f0001.jpg

相似文献

1
The relationship between crystal methamphetamine use and methadone retention in a prospective cohort of people who use drugs.在一个前瞻性吸毒人群队列中,冰毒使用与美沙酮维持治疗留存率之间的关系。
Drug Alcohol Depend. 2021 Aug 1;225:108844. doi: 10.1016/j.drugalcdep.2021.108844. Epub 2021 Jun 24.
2
Methadone Maintenance Treatment Discontinuation Among Young People who use Opioids in Vancouver, Canada.加拿大温哥华的阿片类药物使用者中,美沙酮维持治疗的停药情况。
Can J Psychiatry. 2023 Feb;68(2):89-100. doi: 10.1177/07067437221136468. Epub 2022 Nov 14.
3
Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada.阿片类激动剂治疗的参与和冰毒使用:加拿大温哥华不受监管的阿片类药物使用的影响。
Int J Drug Policy. 2022 Dec;110:103879. doi: 10.1016/j.drugpo.2022.103879. Epub 2022 Oct 18.
4
High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.高强度大麻使用与阿片类激动剂治疗的保留有关:一项纵向分析。
Addiction. 2018 Dec;113(12):2250-2258. doi: 10.1111/add.14398. Epub 2018 Sep 20.
5
Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.澳大利亚注射吸毒者阿片类激动剂治疗中断的发生率及相关因素。
Addiction. 2021 Mar;116(3):525-535. doi: 10.1111/add.15168. Epub 2020 Jul 14.
6
Crystal methamphetamine use and methadone maintenance treatment dissatisfaction: A prospective cohort study in Vancouver, Canada.冰毒使用和美沙酮维持治疗不满:加拿大温哥华的一项前瞻性队列研究。
J Subst Use Addict Treat. 2023 Aug;151:208956. doi: 10.1016/j.josat.2023.208956. Epub 2023 Jan 18.
7
Predictors of crystal methamphetamine use initiation or re-initiation among people receiving opioid agonist therapy: A prospective cohort study.接受阿片类激动剂治疗的人群中开始或重新开始使用甲基苯丙胺的预测因素:一项前瞻性队列研究。
Drug Alcohol Depend. 2022 Nov 1;240:109624. doi: 10.1016/j.drugalcdep.2022.109624. Epub 2022 Sep 10.
8
Factors associated with methadone maintenance therapy discontinuation among people who inject drugs.与注射吸毒者中断美沙酮维持治疗相关的因素。
J Subst Abuse Treat. 2018 Nov;94:41-46. doi: 10.1016/j.jsat.2018.08.009. Epub 2018 Aug 23.
9
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review.冰毒/苯丙胺使用对阿片类药物使用障碍药物治疗的获得和结果的影响:系统评价。
Addict Sci Clin Pract. 2021 Oct 11;16(1):62. doi: 10.1186/s13722-021-00266-2.
10
Increasing diversion of methadone in Vancouver, Canada, 2005-2015.2005-2015 年加拿大温哥华美沙酮转用增多。
J Subst Abuse Treat. 2018 Feb;85:10-16. doi: 10.1016/j.jsat.2017.11.010. Epub 2017 Nov 28.

引用本文的文献

1
Hospital readmissions and emergency department encounters among patients who initiate medications for opioid use disorder during hospitalization: Comparison of patients with and without co-occurring methamphetamine use.住院期间开始使用阿片类物质使用障碍药物治疗的患者的医院再入院情况及急诊科就诊情况:同时使用甲基苯丙胺与未同时使用甲基苯丙胺患者的比较。
J Subst Use Addict Treat. 2025 Oct;177:209765. doi: 10.1016/j.josat.2025.209765. Epub 2025 Jul 30.
2
Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020.接受物质使用治疗的阿片类物质使用障碍患者中兴奋剂使用的趋势:一项2013年至2020年前瞻性队列研究的结果
Drug Alcohol Depend. 2025 Aug 1;273:112703. doi: 10.1016/j.drugalcdep.2025.112703. Epub 2025 May 16.
3

本文引用的文献

1
Awareness of fentanyl exposure and the associated overdose risks among people who inject drugs in a Canadian setting.在加拿大的环境中,注射吸毒者对芬太尼暴露及其相关的过量风险的认识。
Drug Alcohol Rev. 2021 Sep;40(6):964-973. doi: 10.1111/dar.13261. Epub 2021 Feb 18.
2
Characterising the increasing prevalence of crystal methamphetamine use in Vancouver, Canada, from 2006-2017: A gender-based analysis.从 2006 年到 2017 年,对加拿大温哥华地区日益流行的冰毒使用情况进行特征描述:基于性别的分析。
Drug Alcohol Rev. 2020 Nov;39(7):932-940. doi: 10.1111/dar.13126. Epub 2020 Jul 14.
3
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
Non-adherence to treatment and concurrent opioid use among people on methadone maintenance treatment using methamphetamine in Vietnam.越南接受美沙酮维持治疗的人群中使用甲基苯丙胺时的治疗不依从性及同时使用阿片类药物情况
J Subst Use Addict Treat. 2025 Jun;173:209686. doi: 10.1016/j.josat.2025.209686. Epub 2025 Mar 27.
4
Opioid agonist therapy discontinuation in British Columbia: a cross-sectional study of people who access harm reduction services.不列颠哥伦比亚省阿片类激动剂治疗的中断:一项针对接受减少伤害服务人群的横断面研究。
BMJ Open. 2025 Jan 15;15(1):e090704. doi: 10.1136/bmjopen-2024-090704.
5
The Impact of Longitudinal Substance Use Patterns on the Risk of Opioid Agonist Therapy Discontinuation: A Repeated Measures Latent Class Analysis.纵向物质使用模式对阿片类激动剂治疗中断风险的影响:重复测量潜在类别分析
Int J Ment Health Addict. 2024;22(6):4004-4020. doi: 10.1007/s11469-023-01098-8. Epub 2023 Jun 28.
6
How Does Telehealth Expansion Change Access to Healthcare for Patients With Different Types of Substance Use Disorders?远程医疗的扩展如何改变不同类型物质使用障碍患者获得医疗保健的机会?
Subst Use Addctn J. 2024 Jul;45(3):473-485. doi: 10.1177/29767342241236028. Epub 2024 Mar 17.
7
Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant.阿片类药物、甲基苯丙胺和多物质使用:母婴围产期结局
Front Pediatr. 2023 Dec 18;11:1305508. doi: 10.3389/fped.2023.1305508. eCollection 2023.
8
Associations Between Buprenorphine\Naloxone and Methadone Treatment and non-Opioid Substance Use in Prescription-Type Opioid Use Disorder: Secondary Analyses From the OPTIMA Study: Associations entre le traitement avec la buprénorphine/naloxone et avec la méthadone et l'utilisation de substances non opioïdes dans le trouble lié à l'usage d'opioïdes de type sur ordonnance : analyses secondaires de l'étude OPTIMA.丁丙诺啡/纳洛酮与美沙酮治疗及处方类阿片类药物使用障碍中非阿片类物质使用的相关性:来自 OPTIMA 研究的二次分析:丁丙诺啡/纳洛酮与美沙酮治疗及处方类阿片类药物使用障碍中非阿片类物质使用的相关性:来自 OPTIMA 研究的二次分析。
Can J Psychiatry. 2024 Apr;69(4):252-263. doi: 10.1177/07067437231210796. Epub 2023 Oct 30.
9
The impact of polysubstance use patterns on engagement of substance use disorder treatment among emergency department patients at high risk of opioid overdose.多物质使用模式对急诊科阿片类药物过量高风险患者物质使用障碍治疗参与度的影响。
Addict Behav Rep. 2023 Aug 12;18:100512. doi: 10.1016/j.abrep.2023.100512. eCollection 2023 Dec.
10
The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review.甲基苯丙胺使用对阿片类药物使用障碍(MOUD)治疗保留药物的影响:范围综述。
Addict Sci Clin Pract. 2023 Aug 16;18(1):48. doi: 10.1186/s13722-023-00402-0.
治疗兴奋剂使用障碍的处方精神兴奋剂:系统评价和荟萃分析。
Psychopharmacology (Berl). 2020 Aug;237(8):2233-2255. doi: 10.1007/s00213-020-05563-3. Epub 2020 Jun 29.
4
Treatment of stimulant use disorder: A systematic review of reviews.兴奋剂使用障碍的治疗:系统评价综述。
PLoS One. 2020 Jun 18;15(6):e0234809. doi: 10.1371/journal.pone.0234809. eCollection 2020.
5
Retention of patients in opioid substitution treatment: A systematic review.阿片类药物替代治疗中患者的保留情况:系统评价。
PLoS One. 2020 May 14;15(5):e0232086. doi: 10.1371/journal.pone.0232086. eCollection 2020.
6
Understanding concurrent stimulant use among people on methadone: A qualitative study.了解美沙酮使用者同时使用兴奋剂的情况:一项定性研究。
Drug Alcohol Rev. 2020 Mar;39(3):209-215. doi: 10.1111/dar.13049.
7
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.不同阿片类药物使用障碍治疗途径的疗效比较。
JAMA Netw Open. 2020 Feb 5;3(2):e1920622. doi: 10.1001/jamanetworkopen.2019.20622.
8
Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003-2017.涉及可卡因和具有滥用潜力的苯丙胺类兴奋剂的药物过量死亡-美国,2003-2017 年。
MMWR Morb Mortal Wkly Rep. 2019 May 3;68(17):388-395. doi: 10.15585/mmwr.mm6817a3.
9
Evaluation of Amphetamine-Related Hospitalizations and Associated Clinical Outcomes and Costs in the United States.评估美国与苯丙胺类药物相关的住院治疗及相关临床结局和费用。
JAMA Netw Open. 2018 Oct 5;1(6):e183758. doi: 10.1001/jamanetworkopen.2018.3758.
10
Change in alcohol and other drug use during five years of continuous opioid substitution treatment.五年阿片类物质替代治疗期间酒精和其他药物使用的变化。
Drug Alcohol Depend. 2019 Jan 1;194:438-446. doi: 10.1016/j.drugalcdep.2018.11.008. Epub 2018 Nov 26.